SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-034802
Filing Date
2022-09-27
Accepted
2022-09-27 11:30:18
Documents
13
Period of Report
2022-09-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10042283_8k.htm   iXBRL 8-K 35064
2 EXHIBIT 99.1 brhc10042283_ex99-1.htm EX-99.1 6650
  Complete submission text file 0001140361-22-034802.txt   180042

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20220927.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220927_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220927_pre.xml EX-101.PRE 16040
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10042283_8k_htm.xml XML 4054
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221268339
SIC: 2835 In Vitro & In Vivo Diagnostic Substances